The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Dr Cheng Boon is Consultant Clinical Oncologist at the Worcester Oncology Centre at Worcester Royal Hospital. He completed medical training at the University of Manchester Medical School.
Dr Boon specialises in the non-surgical management of solid organ malignancies of the head and neck and upper gastrointestinal tract, in radiotherapy for plasmacytoma and lymphoma as well as in chemotherapy for gynaecological malignancies. His objective is to harness technology to offer complex, modern radiotherapy, improving survival and limiting toxicities to normal tissue.
Dr Boon sits on a panel of clinicians that helps screen early clinical trial proposals for radiation safety and exposure purposes.
Fellowship of the Royal College of Radiology (United Kingdom)
Clinical Oncology Specialist Register of the General Medical Council (United Kingdom)
Clinical Radiation Expert (CRE) for Health Research Authority (HRA), National Health Service (NHS)
Honorary Senior Lecturer (Radiotherapy Quality Assurance), Institute of Head and Neck Studies and Education (InHANSE)
Dr Cheng Boon does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Dr Cheng Boon does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Dr Cheng Boon does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.